Protocol for in vitro establishment of heterogeneous stem-like cultures derived from whole human glioblastoma tumors.

Cancer Cell culture Cell isolation Flow Cytometry Stem Cells

Journal

STAR protocols
ISSN: 2666-1667
Titre abrégé: STAR Protoc
Pays: United States
ID NLM: 101769501

Informations de publication

Date de publication:
14 Nov 2023
Historique:
received: 31 07 2023
revised: 13 09 2023
accepted: 20 10 2023
medline: 17 11 2023
pubmed: 17 11 2023
entrez: 16 11 2023
Statut: aheadofprint

Résumé

Cultures enriched in glioblastoma stem-like cells (GSCs) are prominent in vitro models to investigate molecular determinants and therapeutic targets of glioblastoma; however, conventional GSC derivation protocols fail to preserve GSC heterogeneity. Here, we present a protocol for the propagation of heterogeneous GSC cultures starting from cell resuspensions containing the entire tumor mass. We describe steps for isolation of GSCs and their maintenance and expansion in culture. We then detail procedures for preliminary analysis to be performed on freshly isolated material. For complete details on the use and execution of this protocol, please refer to De Bacco et al.

Identifiants

pubmed: 37971942
pii: S2666-1667(23)00672-X
doi: 10.1016/j.xpro.2023.102705
pmc: PMC10684815
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102705

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Nat Rev Cancer. 2022 Sep;22(9):497-514
pubmed: 35710946
Neuro Oncol. 2021 Feb 25;23(2):199-213
pubmed: 33173943
Methods Protoc. 2021 Jan 26;4(1):
pubmed: 33530325
Cancer Res. 2003 Sep 15;63(18):5821-8
pubmed: 14522905
Science. 1992 Mar 27;255(5052):1707-10
pubmed: 1553558
Sci Rep. 2016 Sep 08;6:32788
pubmed: 27605047
Cell Stem Cell. 2019 Jan 3;24(1):25-40
pubmed: 30595497
Cancers (Basel). 2013 Apr 03;5(2):357-71
pubmed: 24216981
Cancer Cell. 2020 May 11;37(5):630-636
pubmed: 32396858
Cell Rep. 2023 Aug 29;42(8):112816
pubmed: 37505981
J Clin Invest. 2017 Feb 1;127(2):415-426
pubmed: 28145904
Cancer Res. 2004 Oct 1;64(19):7011-21
pubmed: 15466194
Glia. 2002 Sep;39(3):193-206
pubmed: 12203386
Cancer Discov. 2021 Mar;11(3):575-590
pubmed: 33558264
Methods Enzymol. 2006;419:3-23
pubmed: 17141049
Cell Stem Cell. 2011 May 6;8(5):486-98
pubmed: 21549325
Cell Stem Cell. 2009 Jun 5;4(6):568-80
pubmed: 19497285

Auteurs

Francesca De Bacco (F)

Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Turin, Italy; Department of Oncology, University of Turin Medical School, 10060 Candiolo, Turin, Italy. Electronic address: francesca.debacco@ircc.it.

Francesca Orzan (F)

Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Turin, Italy; Department of Oncology, University of Turin Medical School, 10060 Candiolo, Turin, Italy. Electronic address: francesca.orzan@ircc.it.

Elena Casanova (E)

Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Turin, Italy. Electronic address: elena.casanova@ircc.it.

Marta Prelli (M)

Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Turin, Italy; Department of Oncology, University of Turin Medical School, 10060 Candiolo, Turin, Italy.

Carla Boccaccio (C)

Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Turin, Italy; Department of Oncology, University of Turin Medical School, 10060 Candiolo, Turin, Italy. Electronic address: carla.boccaccio@ircc.it.

Classifications MeSH